You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康寧傑瑞製藥-B(09966.HK):董事及高級管理層增持90萬股股份

格隆匯7月17日丨康寧傑瑞製藥-B(09966.HK)發佈公告,董事會已獲執行董事及公司若幹高級管理層成員告知,自2025年7月14日至7月16日,彼等已於公開市場按7.257港元的平均交易價格購入合共90萬股股份。

董事會已獲公司首席執行官兼執行董事徐霆博士進一步告知,繼徐霆博士於2020年5月21日(緊接該日前股份的收市價爲23.10港元)根據公司於2018年10月16日採納的首次公開發售前購股權計劃一(經不時修訂)(“首次公開發售前購股權計劃一”)行使455.295萬份購股權後,彼已於2025年7月16日(緊接該日前股份的收市價爲7.49港元)進一步行使根據首次公開發售前購股權計劃一授予彼的900.589萬份購股權。

上述董事及高級管理層成員表示對公司的整體發展前景、增長潛力及其股份的長期投資價值充滿信心。在遵守適用法律及監管規定的前提下,並不排除其可能適時進一步增持公司股份。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account